2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+))

C113H140N28Pt4 — CID 160780266

IUPAC2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+))
SMILESCC(C)(C)c1cc(-c2nccc(-c3[n-]nc4c3CCCC4(C)C)n2)[n-]n1.CC(C)(C)c1cc(-c2nccc(-c3[n-]nc4c3CCCC4)n2)[n-]n1.CC(C)(C)c1cc(-c2nccc(-c3[n-]nc4ccccc34)n2)[n-]n1.CC(C)(C)c1ccncc1.CC(C)(C)c1ccncc1.CC(C)(C)c1ccncc1.CC(C)(C)c1ccncc1.CC(C)Cc1n[n-]c(-c2ccnc(-c3cc(C(C)(C)C)n[n-]3)n2)c1C(C)C.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C21H28N6.C20H24N6.C18H20N6.C18H16N6.4C9H13N.4Pt/c1-12(2)10-15-18(13(3)4)19(27-24-15)14-8-9-22-20(23-14)16-11-17(26-25-16)21(5,6)7;1-19(2,3)15-11-14(23-24-15)18-21-10-8-13(22-18)16-12-7-6-9-20(4,5)17(12)26-25-16;2*1-18(2,3)15-10-14(22-23-15)17-19-9-8-13(20-17)16-11-6-4-5-7-12(11)21-24-16;4*1-9(2,3)8-4-6-10-7-5-8;;;;/h8-9,11-13H,10H2,1-7H3;8,10-11H,6-7,9H2,1-5H3;8-10H,4-7H2,1-3H3;4-10H,1-3H3;4*4-7H,1-3H3;;;;/q4*-2;;;;;4*+2
InChIKeySAMFZXXBAGISHI-UHFFFAOYSA-N
MW2670.87 g/mol
LogP22.72
Rot. Bonds11

About 2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+))

2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+)) (PubChem CID 160780266) has the molecular formula C113H140N28Pt4 and a molecular weight of 2670.87 g/mol. Its IUPAC name is 2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+)).

Molecular Properties

Compound Name2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+))
PubChem CID160780266
Molecular FormulaC113H140N28Pt4
Molecular Weight2670.87 g/mol
Exact Mass2669.04
IUPAC Name2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+))
SMILESCC(C)(C)c1cc(-c2nccc(-c3[n-]nc4c3CCCC4(C)C)n2)[n-]n1.CC(C)(C)c1cc(-c2nccc(-c3[n-]nc4c3CCCC4)n2)[n-]n1.CC(C)(C)c1cc(-c2nccc(-c3[n-]nc4ccccc34)n2)[n-]n1.CC(C)(C)c1ccncc1.CC(C)(C)c1ccncc1.CC(C)(C)c1ccncc1.CC(C)(C)c1ccncc1.CC(C)Cc1n[n-]c(-c2ccnc(-c3cc(C(C)(C)C)n[n-]3)n2)c1C(C)C.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C21H28N6.C20H24N6.C18H20N6.C18H16N6.4C9H13N.4Pt/c1-12(2)10-15-18(13(3)4)19(27-24-15)14-8-9-22-20(23-14)16-11-17(26-25-16)21(5,6)7;1-19(2,3)15-11-14(23-24-15)18-21-10-8-13(22-18)16-12-7-6-9-20(4,5)17(12)26-25-16;2*1-18(2,3)15-10-14(22-23-15)17-19-9-8-13(20-17)16-11-6-4-5-7-12(11)21-24-16;4*1-9(2,3)8-4-6-10-7-5-8;;;;/h8-9,11-13H,10H2,1-7H3;8,10-11H,6-7,9H2,1-5H3;8-10H,4-7H2,1-3H3;4-10H,1-3H3;4*4-7H,1-3H3;;;;/q4*-2;;;;;4*+2
InChIKeySAMFZXXBAGISHI-UHFFFAOYSA-N
XLogP22.72
TPSA370.60 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds11
Heavy Atoms145
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002670.87
LogP ≤ 522.72
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Analyze 2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+))?
The IUPAC name of 2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+)) (CID 160780266) is 2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+)).
What is the SMILES notation for 2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+))?
The canonical SMILES for 2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+)) is CC(C)(C)c1cc(-c2nccc(-c3[n-]nc4c3CCCC4(C)C)n2)[n-]n1.CC(C)(C)c1cc(-c2nccc(-c3[n-]nc4c3CCCC4)n2)[n-]n1.CC(C)(C)c1cc(-c2nccc(-c3[n-]nc4ccccc34)n2)[n-]n1.CC(C)(C)c1ccncc1.CC(C)(C)c1ccncc1.CC(C)(C)c1ccncc1.CC(C)(C)c1ccncc1.CC(C)Cc1n[n-]c(-c2ccnc(-c3cc(C(C)(C)C)n[n-]3)n2)c1C(C)C.[Pt+2].[Pt+2].[Pt+2].[Pt+2].
What is the InChIKey of 2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+))?
The InChIKey is SAMFZXXBAGISHI-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H28N6.C20H24N6.C18H20N6.C18H16N6.4C9H13N.4Pt/c1-12(2)10-15-18(13(3)4)19(27-24-15)14-8-9-22-20(23-14)16-11-17(26-25-16)21(5,6)7;1-19(2,3)15-11-14(23-24-15)18-21-10-8-13(22-18)16-12-7-6-9-20(4,5)17(12)26-25-16;2*1-18(2,3)15-10-14(22-23-15)17-19-9-8-13(20-17)16-11-6-4-5-7-12(11)21-24-16;4*1-9(2,3)8-4-6-10-7-5-8;;;;/h8-9,11-13H,10H2,1-7H3;8,10-11H,6-7,9H2,1-5H3;8-10H,4-7H2,1-3H3;4-10H,1-3H3;4*4-7H,1-3H3;;;;/q4*-2;;;;;4*+2.
What are the key properties of 2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+))?
2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+)) has a molecular weight of 2670.87 g/mol, XLogP of 22.72, 11 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(3-tert-butylpyrazol-1-id-5-yl)-4-[3-(2-methylpropyl)-4-propan-2-ylpyrazol-1-id-5-yl]pyrimidine;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-7,7-dimethyl-5,6-dihydro-4H-indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]indazol-2-ide;3-[2-(3-tert-butylpyrazol-1-id-5-yl)pyrimidin-4-yl]-4,5,6,7-tetrahydroindazol-2-ide;tetrakis(4-tert-butylpyridine);tetrakis(platinum(2+)) is sourced from PubChem (CID 160780266), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).